ASX:RAP
| |
Last |
Movement |
Open |
High |
Low |
Volume |
| ASX:RAP |
$0.190 |
$0.003 |
1.55% |
$0.190 |
$0.200 |
$0.185 |
538,679 |
Data Source: 
Last Updated: 19/06/2019 1:05 PM
Company News /
by Rachael Jones -
21 days ago
29 May 2019 - Digital health company ResApp Health (ASX:RAP) has engaged a UK-based medical device consultant to develop customised hardware and wearable devices capable of running…
Market Reports /
by Rachael Jones -
A month ago
23 Apr 2019 - It has been a positive day of trade for the ASX. After opening in the black the local bourse managed to maintain momentum to gain 1%. Appen (ASX:APX) share price surg…
Company News /
by Rachael Jones -
A month ago
23 Apr 2019 - Digital health smartphone company for respiratory disease, ResApp Health (ASX:RAP) has announced positive top-line results from its Australian Breathe Easy adult clin…
Company Presentations /
by -
6 months ago
13 Dec 2018 - ResApp Health Limited (ASX:RAP) Managing Director and CEO Tony Keating provides an update on trial results, regulatory approval for the company's respiratory diagnosi…
Interviews /
by Anna Napoli -
6 months ago
13 Dec 2018 - ResApp Health Limited (ASX:RAP) Managing Director and CEO Tony Keating provides an update on trial results, regulatory approval for the company's respiratory diagnosi…
Company News /
by Anna Napoli -
9 months ago
19 Sep 2018 - ResApp (ASX:RAP) has today announced its received firm commitments from institutional and sophisticated investors to raise $7.5 million.
Market Reports /
by Rachael Jones -
A year ago
06 Jun 2018 - Australian shares opened stronger but struggled to hold gains. We saw a dip prior to the release of the latest GDP figures which were above expectation and the market…
Market Reports /
by Jessica Ellerm -
A year ago
08 Jan 2018 - Momentum continues on Monday: Aus shares 0.22% higher at noon. ResApp Health Limited (ASX:RAP) announces it has enrolled the first patient in its SMARTCOUGH-C-2 study…
Company Presentations /
by -
A year ago
18 Sep 2017 - ResApp Health (ASX:RAP) Executive Director Brian Leedman talks about its world's first digital diagnostic smartphone cough app trial results, time frame for FDA appro…
Interviews /
by Jessica Amir -
A year ago
18 Sep 2017 - ResApp Health (ASX:RAP) Executive Director Brian Leedman talks about the company's trial results from its paediatric and adult programs, time frame for FDA approval a…
Market Reports /
by Carolyn Herbert -
A year ago
09 Aug 2017 - Back in the black: Aus shares 0.42% higher at noon. ResApp Health (ASX:RAP) shares have been sold off following the company’s latest update on its SMARTCOUGH- C Stud…
Market Reports /
by Carolyn Herbert -
A year ago
02 Aug 2017 - Negative territory: Aus shares close 0.49% lower. ResApp Health Limited (ASX:RAP) has been placed into voluntary suspension, pending the release of an announcement r…
Market Reports /
by Carolyn Herbert -
A year ago
31 July 2017 - Sluggish start: Aus shares 0.32% higher at noon. IMF Bentham Limited (ASX:IMF) has announced that it will fund on a conditional basis claims of certain current and …
Company News /
by Carolyn Herbert -
A year ago
22 Jun 2017 - ResApp Health Limited (ASX:RAP) says it has delivered excellent results in its Australian pediatric SmartCough C study.
Market Reports /
by Carolyn Herbert -
2 years ago
19 June 2017 - In the black: Aus shares 0.52% higher at noon. Pilbara Minerals Limited (ASX:PLS) has announced it has successfully raised $80 million in a heavily oversubscribed p…
Company Presentations /
by Carolyn Herbert -
2 years ago
08 Mar 2017 - ResApp Health (ASX:RAP) Managing Director & CEO Tony Keating presents at the ASX CEO Sessions in Sydney.
Interviews /
by Carolyn Herbert -
2 years ago
08 Mar 2017 - ResApp Health (ASX:RAP) Managing Director & CEO, Dr Tony Keating, discusses the path to commercialising its smartphone app which diagnoses respiratory diseases
Market Reports /
by Carolyn Herbert -
2 years ago
10 Jan 2016 - Market backtrack: Aus shares 0.85% lower at noon. Paladin Energy Limited (ASX:PDN) has entered into a proposal to restructure its balance sheet, which will subsequent…
Market Reports /
by Carolyn Herbert -
2 years ago
11 Nov 2016 - High note: Aus shares close 0.8% higher. The Charter Hall Retail REIT (ASX:CQR) says its well placed to deliver on its stated strategies in FY17.
Company News /
by Jessica Ellerm -
2 years ago
11 Nov 2016 - ResApp Health Limited (ASX:RAP) announces it has received institutional review board approval at the Massachusetts General Hospital for its SMARTCOUGH-C study.
Company News /
by Jessica Ellerm -
2 years ago
21 Oct 2016 - ResApp Health Limited (ASX:RAP) announces it has received its first institutional review board approval for its SMARTCOUGH-C study.
Company News /
by Jessica Ellerm -
2 years ago
03 Oct 2016 - ResApp Health Limited (ASX:RAP) announces further positive results from an adult clinical study into its sound-based respiratory diagnosis technology.
Company News /
by David Chau -
2 years ago
15 Sep 2016 - ResApp Health Ltd (ASX:RAP) ships smartphones to a 'leading global humanitarian organisation' to field-test diagnostic app.
Market Reports /
by Carolyn Herbert -
2 years ago
20 Jul 2016 - Healthcare in focus: Aus shares up 0.43% at lunch. ResApp Health Limited (ASX:RAP) has announced that it is planning to conduct a clinical study with Massachusetts G…
Market Reports /
by Carolyn Herbert -
2 years ago
07 Jul 2016 - Aus shares close 0.59% higher; energy excels. ResApp Health Limited (ASX:RAP) has responded to an ASX price and volume query regarding a sell-down of its securities …
